Pharma Marketing Network

APRIL 16, 2025

Imagine launching a brand campaign without guessworkwhere your message reaches the right healthcare professional at the right time on the right channel. Thats the promise of data-driven marketing , a strategy thats rapidly transforming how pharmaceutical companies approach promotion, education, and engagement in 2025. As privacy regulations evolve, customer expectations change, and AI-driven technologies emerge, pharma marketers must adapt or risk becoming irrelevant.

HIPAA 59

HIPAA Documentation Pharmaceutical Companies Pharmaceutical Companies 59

STAT

APRIL 17, 2025

UnitedHealth Group on Thursday lowered its profit outlook for the rest of this year after the health care conglomerate said its Medicare Advantage members continued to seek more medical care than it anticipated.  The higher use of care among these Medicare enrollees “was most notable within physician and outpatient services,” UnitedHealth said in its first-quarter earnings release.

362

362

Putting Patients First Blog

APRIL 17, 2025

NHC Letter to Congress: Protect Medicaid Access for Americans with Chronic Conditions and Disabilities (PDF) April 17, 2025 The Honorable John Thune The Honorable Chuck Schumer Majority Leader Minority Leader United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Mike Johnson The Honorable Hakeem Jeffries Speaker Minority Leader U.S.

122

122

PharmaVoice

APRIL 18, 2025

Compass Pathways expects to publish the first phase 3 results from a large-scale, psilocybin drug trial by the end of this quarter.

278

278

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

APRIL 14, 2025

At the recently held 2025 American Academy of Neurology (AAN) meeting, Remegen presented positive Phase III results for telitacicept in patients with AChR+ or MuSK+ generalised myasthenia gravis (gMG). The B cell-targeting therapy demonstrated a favorable efficacy and safety profile over 24 weeks, showing clinically meaningful improvement. These findings position telitacicept as a potential challenger to the existing disease-modifying therapies (DMTs), says GlobalData.

Biosimilars 95

Biosimilars Labelling 95

National Association of Boards of Pharmacy

APRIL 16, 2025

At NABP, we offer pharmacist examinations like the North American Pharmacist Licensure Examination (NAPLEX) and the Multistate Pharmacy Jurisprudence Examination (MPJE) to assess a pharmacists competency to practice while protecting the public health. In our last blog post, we discussed the development and the recent improvements that have been made to the MPJE and its purpose: to evaluate candidates understanding and application of federal and state-specific laws and regulations.

76

76

PharmaVoice

APRIL 16, 2025

Lower operating costs and a supply of high-skilled workers are helping the North Carolina region pull in billions of pharma manufacturing investments.

252

252

Express Pharma

APRIL 12, 2025

Panellists in this video: Mr Ajay Bapat, Pharma Consultant (MODERATOR) Mr Manoj Kumar, Cluster Lead Packaging, Sun Pharma Mr Prafull V Deshpande, Team leader Packaging Development, Lupin Mr Kumar Suman, AGM & Head Packaging Development (Injectables and Medical Devices), Macleods Pharmaceuticals Mr Iranna SB, VP MSAT, Maiva Pharma Key Highlights: [1] Any innovation is truly successful only when it generates business value or is cost-efficient [2] The industry should actively promote

Packaging 105

Packaging 105

STAT

APRIL 14, 2025

An estimated 4 million Americans are infected with hepatitis C, a disease that can go undetected for years. Another 2.4 million people in this country are chronically infected with hepatitis B, which is the leading cause of liver cancer globally. Hepatitis B is preventable, and hepatitis C is curable. But the U.S. capacity to battle these viral scourges has been leveled a devastating blow with the April 1 closure of the country’s premier testing laboratory for viral hepatitis, experts war

352

352

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Pharmafile

APRIL 14, 2025

Eyestem Research, an Indian biotech company, announced successful results from its phase 1 trial of Eyecyte-RPE, a potential therapy for a rare form of dry age-related macular degeneration (AMD), geographic atrophy (GA). GA is an advanced form of AMD, which affects a small number of AMD patients. The phase 1 trial found advancement in visual […] The post Successful trial results announced for potential rare eye disease treatment appeared first on Pharmafile.

89

89

PharmaVoice

APRIL 14, 2025

Major changes to the dynamics of the pharmaceutical ecosystem are making executive decisions even tougher.

223

223

Express Pharma

APRIL 12, 2025

Panellists in this video: Mr Rahul Bhargava, Director R&D Packaging, Packaging Prescriptions (MODERATOR) Mr Srinivas Sukasi, AGM, Packaging Development, MSN Laboratories Mr G V Srinivas, Associate Director Packaging Research & Development, DifGen Pharmaceuticals Mr Bhupesh Mittal, Technical Packaging Program Lead APAC, Bayer Consumer Healthcare Mr Bangarayya Mathamsetti, Senior Manager Packaging and Development, Lyrus Life Sciences Mr Rajendra Shetty, Senior Manager Packagin

Packaging 101

Packaging 101

STAT

APRIL 16, 2025

A federal judge has given the go-ahead for a class-action lawsuit that could radically expand Americans’ access to lifesaving addiction medications.  The perhaps surprising defendant: The Salvation Army, the Christian charity known more for its thrift stores than for its nationwide network of addiction treatment facilities.

340

340

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

Drug Patent Watch

APRIL 14, 2025

"Compliance in Generic Drug Development: A Critical Component of Success As the generic drug industry continues to grow, ensuring compliance with regulatory requirements has become a top priority for pharmaceutical companies. At DrugPatentWatch, we've seen firsthand the importance of staying on top of regulatory changes and maintaining a robust compliance program.

Drug Development 84

Drug Development Pharmaceutical Companies Pharmaceutical Companies 84

The Pharmacist

APRIL 14, 2025

Some 66 pharmacies in the North West can now apply to deliver the respiratory syncytial virus (RSV) and pertussis (whooping cough) vaccine, under a new NHS England invitation to tender. It follows an earlier tender of the service in the Midlands region, which closed last month. The North West tender, published last week, sets out […] The post North West pharmacies invited to apply for RSV and pertussis vaccine service appeared first on The Pharmacist.

Vaccines 81

Vaccines 81

Express Pharma

APRIL 16, 2025

The Ministry of Health and Family Welfare, Government of India, has issued a notification restricting the manufacture, sale and distribution of all formulations of the fixed dose combination (FDC) of Chlorpheniramine Maleate and Phenylephrine Hydrochloride for use in children below four years of age. The notification, dated 15 April 2025, was issued under Section 26A of the Drugs and Cosmetics Act, 1940 (23 of 1940), citing the potential risk of using the said FDC in children under four and the

Packaging 90

Packaging Labelling 90

STAT

APRIL 13, 2025

In an unusual move, an audit of commercial health plans by Tennessee officials found that Express Scripts, one of the largest pharmacy benefit managers in the United States, violated state laws in its dealings with pharmacies, according to newly released documents. Specifically, the company failed to properly reimburse pharmacies, favored its own specialty pharmacy operations by paying higher dispensing fees than to other pharmacies, and did not properly handle appeals filed by pharmacies, accor

Specialty Pharmacies 363

Specialty Pharmacies Documentation Drug Pricing 363

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Quality Matters

APRIL 17, 2025

Over half of the active pharmaceutical ingredients (API) for prescription medicines in the U.S. come from India and the European Union This blog is part of a series on the geographic concentration of pharmaceutical manufacturing. This blog focuses on the manufacturing of active pharmaceutical ingredients (API). For a discussion on finished dose manufacturing, seehere.

Pharmaceutical Manufacturing 65

Pharmaceutical Manufacturing 65

Pharmafile

APRIL 16, 2025

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) rates of newly diagnosed multiple myeloma (NDMM) than conventional bortezomib, lenalidomide and dexamethasone (VRd) chemotherapy. The treatment could help NDMM patients approach normal expectancy without their disease progressing, with PFS projected to be 17 years. […] The post Johnson & Johnson announces successful

Chemotherapy 66

Chemotherapy 66

Express Pharma

APRIL 13, 2025

Following the overturn of Leqselvis injunction in the US market on 10 April 2025: Vinie Varkey, Pharma Analyst at GlobalData offers her view, Sun Pharmas Leqselvi has a strong chance to see quick patient uptake in the US. The JAK 1/2 inhibitor was approved by the FDA in July 2024 for treatment of adults with severe alopecia areata (AA); however, a patent ruling in November 2024 resulted in an injunction blocking the commercial release of the drug in the US.

82

82

STAT

APRIL 14, 2025

Verve Therapeutics said initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects, a positive step for the company after it paused development of an earlier treatment due to safety concerns. The early data from an ongoing Phase 1 study show that a single infusion of the therapy, called Verve-102, led to greater decreases in “bad” LDL cholesterol with higher doses, according to an announcement Monday.

360

360

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

European Pharmaceutical Review

APRIL 14, 2025

New research has proposed a method to increase the effectiveness of tumour-infiltrating lymphocyte (TIL) immunotherapy. Investigators identified that the natural immune protein called CD40L was key in improving TIL cultures in the lab. We discovered that by adding CD40L to the immune cells in the lab, we could dramatically improve the number and quality of cancer-fighting T cells were able to grow, explained Daniel Abate-Daga, PhD, lead author of the study and Scientific Director of the Cell The

Immunization 59

Immunization Immunity 59

PharmaVoice

APRIL 17, 2025

The non-traditional marketing approach comes amid a potential crackdown on TV drug ads.

147

147

Express Pharma

APRIL 16, 2025

Parexel, a global clinical research organisation (CRO) offering end-to-end Phase I to IV clinical development services, has announced the appointment of Charlotte Moser, MD, PhD, MBA, as its new Chief Medical Officer. The company stated that this leadership change aligns with its focus on advancing global clinical research through strategic drug development and therapeutic expertise.

Medical Schools 90

Medical Schools Drug Development 90

STAT

APRIL 14, 2025

Capping more than two years of stock-gyrating drama, Pfizer said Monday that it would stop development of danuglipron, its experimental oral GLP-1 medicine to treat obesity, focusing its efforts on another medicine with a different mechanism of action. Pfizer said in a press release that an asymptomatic volunteer in the company’s studies experienced “potential drug-induced liver injury,” which resolved after stopping the medication.

356

356

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

Pharmafile

APRIL 17, 2025

Allegros hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment for osteoarthritis. This was announced at the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO) in Rome, Italy. The product, known as microparticle hydrogel hydrocelin, was announced as being non-pyrogenic following a series of […] The post Allegro confirms successful safety testing of osteoarthr

64

64

Drug Patent Watch

APRIL 16, 2025

"Patent Expiration: The Secret to Unlocking $100 Billion in Pharmaceutical Value Did you know that patent expirations in the pharmaceutical industry are projected to unlock over $100 billion in new business opportunities? At Drug Patent Watch, we've analyzed the latest data to reveal the top 5 therapeutic areas poised for disruption. From oncology to cardiovascular disease, we've identified the key trends and insights you need to know to make informed investment decisions.

74

74

Express Pharma

APRIL 12, 2025

Panellists in this video: Mr Chakravarthi AVPS, Global Ambassador, World Packaging Organisation (MODERATOR) Dr Ranjana Pathak, Chief Quality Officer, Lupin Mr Sheetal Arora, CEO, Mankind Pharma Key Highlights: [1] Innovation and leadership are interlinked. An innovative mindset will be crucial to pave India Pharma Incs path to global leadership [2] Quality must be the cornerstone of pharmait should be felt, experienced and ingrained in every aspect of the industry. [3] Practicality, proactive

Packaging 87

Packaging 87